Moreover, specific ROR ligands, such as SR1078, have been demonstrated to inhibit aerobic glycolysis in hepatoma cells, underscoring the therapeutic potential of targeting RORs to intervene in metabolic pathways critical for the survival of cancer cells [70]. The gene discussed is LINC-ROR; the disease is hepatocellular carcinoma.